JP Patent

JP6814886B2 — ベンゾイミダゾール誘導体を含む新規な製剤

Assigned to HK Inno N Corp · Expires 2021-01-20 · 5y expired

What this patent protects

Patent listed against azilsartan-kamedoxomil.

Drugs covered by this patent

azilsartan-kamedoxomil (AZILSARTAN KAMEDOXOMIL)

Patent Metadata

Patent number: JP6814886B2
Jurisdiction: JP
Classification: —
Expires: 2021-01-20
Drug substance claim: No
Drug product claim: No
Assignee: HK Inno N Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.